News | Mammography | November 10, 2015

Flat panel display can now be used for 3-D mammography, breast MRI and ultrasound

Barco, Coronis Uniti, clearance, multimodality breast imaging

Image courtesy of Barco


November 10, 2015 — Healthcare imaging specialist Barco announced in October that its flagship diagnostic display system, Coronis Uniti, has been clinically validated for multimodality breast imaging. This makes Coronis Uniti the world’s first and only diagnostic display that can be used for both picture archiving and communication systems (PACS) and multimodality breast imaging, including breast tomosynthesis, 3-D mammography, breast magnetic resonance imaging (MRI) and breast ultrasound.

The system had previously been cleared for viewing PACS and mammography images, including breast tomosynthesis. The U.S. Food and Drug Administration’s (FDA) new indications for use include breast MRI, breast ultrasound, computed tomography (CT) and ultrasound, including vascular and gynecological ultrasound. This enables radiologists to view a host of breast imaging modalities – in color or grayscale, 2-D or 3-D, static or dynamic – on a single display. 

The ability to access any image on a single display offers significant benefits, from workflow and clinical perspectives. First of all, it eliminates the need to change workstations to complete patient studies. Additionally, running side-by-side comparisons and image fusions have proven to positively impact diagnostic interpretation. The use of ultrasound in combination with conventional mammography in women with dense breasts, for example, has resulted in better early breast cancer detection

Differences in the visual appearance of different image types posed additional challenges, which Barco tackled by introducing proprietary technologies to automatically set the proper color and grayscale settings for every image modality – even when viewing them simultaneously on the screen. 

Barco also found a way to counteract motion blur when reviewing multi-frame image sequences such as digital breast tomosynthesis, breast ultrasound and breast MRI. Thanks to RapidFrame technology, which provides a high pixel refresh rate, Coronis Uniti enables radiologists to accurately visualize moving and changing images, avoiding loss of detail when scrolling through the 3-D stack and ensuring efficient diagnosis as well as swift workflow. 

For more information: www.barco.com


Related Content

Videos | Breast Imaging

Don't miss ITN's latest "One on One" video interview with AAWR Past President and American College of Radiology (ACR) ...

Time April 15, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Radiation Dose Management

April 11, 2024 — Prelude Corporation (PreludeDx), a leader in precision diagnostics for early-stage breast cancer ...

Time April 11, 2024
arrow
News | Mammography

April 11, 2024 — Volpara Health Technologies Ltd., a global leader in software for the early detection and prevention of ...

Time April 11, 2024
arrow
News | Society of Breast Imaging (SBI)

April 11, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced today ...

Time April 11, 2024
arrow
Feature | Radiation Oncology | By Melinda Taschetta-Millane

In a new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS ...

Time April 10, 2024
arrow
News | Ultrasound Imaging

April 9, 2024 — A new Society of Radiologists in Ultrasound (SRU) expert consensus statement to improve endometriosis ...

Time April 09, 2024
arrow
News | Artificial Intelligence

April 9, 2024 —PreciseDx, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for ...

Time April 09, 2024
arrow
News | Breast Imaging

April 8, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, is proud to ...

Time April 08, 2024
arrow
Subscribe Now